Stock fact sheet · data as of

Cyanotech Corporation (CYAN): fair value, margin of safety and Wheel Score

Consumer Defensive · Packaged Foods · United States · Speculative / Distressed

Close0.7000
GLS fair value0.29351 of 9 models
Margin of safety-138%price above fair value
Wheel Score19No optionscapped: no options
Health5/9Piotroski F-score
Moat1.3/10GLS 10-year score
Market cap$5M1k shares a day
Implied vol.-no listed options
P/E-EPS -0.01
Dividend yieldnone
Beta0.11moves less than the market
Next earnings-no date recorded

Is CYAN undervalued?

Cyanotech Corporation (CYAN) closed at 0.7000 on 16 Oct 2026, 138% above the GLS average fair value of 0.2935. 1 of the 1 models that produced a number value the shares below the current price. A gap this wide usually means the market is paying for growth or a story the trailing numbers do not show yet; the models work from filed results, not forecasts, so they are conservative by design.

The average is built from just 1 models (10 Cap) - the rest returned nothing because an input they need (dividends, free cash flow, book value) is zero or negative - so treat it with more caution than usual.

The nightly engine files CYAN under Speculative / Distressed - negative earnings or a Piotroski score of 3 or less - which caps its Wheel Score at 45 and keeps it out of the Sunday Scan.

Nine valuation models for CYAN

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

ModelValuevs priceWhat it measures
DCF--Present value of the projected free cash flows, discounted at the cost of capital; no value tonight
Graham Number--The most a defensive investor pays for the earnings and book value per share; no value tonight
Graham Growth--Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields; no value tonight
Lynch--EPS × the earnings growth rate (PEG of 1), growth capped at 25%; no value tonight
GLS Growth--EPS compounded ten years at the blended growth rate, discounted back at 15% a year; no value tonight
10 Cap0.2935-58%Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%
Payback Time--Eight years of compounded free cash flow: the price at which the business pays for itself; no value tonight
DDM--Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight
EPV--Earnings power value: current EPS capitalised at 9% with no growth; no value tonight
Zombie (liquidation)-0.4862-169%Current assets less all liabilities, per share: the balance-sheet floor. Not in the average
Wall St target0.0000-100%Analysts' average 12-month price target. Not in the average

Quality and financial health

Cyanotech Corporation scores 5 of 9 on the Piotroski F-score: a middling result that falls one point short of the Sunday Scan's "6 or more" rule. Some of the nine tests on profitability, leverage and efficiency are failed, so the accounts are worth a look before selling a put on the name. A GLS Moat score of 1.3/10 is a weak reading: the ten-year history the score grades (revenue, EPS, book value, margins, cash flow, share count, ROIC) has not been steady, so the Moat part of the Wheel Score contributes little.

Returns on capital are thin or negative - ROIC -6.7%, ROE -16.7%, ROA -5.8% - with debt at 1.51 times equity and a free-cash-flow yield of 1.1%.

Cyanotech Corporation pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain. Revenue comes mainly from Packaged Products 33%, Packaged Astaxanthin 24%, Bulk Products 17% (quarter Q2 FY2026).

Institutional ownership scores 5/10, insider activity 5/10 and Congressional trading 5/10 on the GLS smart-money scales.

Piotroski F-score5 / 9ROIC-6.7%
GLS Moat1.3 / 10ROE-16.7%
Debt / equity1.51ROA-5.8%
Free-cash-flow yield1.1%Payout ratio0%
Institutions5 / 10Insiders · Congress5 · 5 / 10

Wheel Score 19: No options

No options are listed on Cyanotech Corporation in our nightly snapshot. The Wheel Score is therefore capped at 39 (it reads 19) and the stock is left out of every options screen; the fair value and health figures above are still useful for a plain stock position.

Volume runs at 1k shares a day on a market cap of $5M, with a beta of 0.11 - a low beta, so day-to-day moves are smaller than the market's; the Stability part of the Wheel Score gives that 6 of 20.

PartPointsFrom
Value0 / 25-138% margin of safety
Health11 / 20Piotroski 5/9
Moat2 / 15moat 1.3/10
Premium0 / 20no option data
Stability6 / 201k shares/day, $5M cap, beta 0.11

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.

Upcoming events

No upcoming earnings date is recorded for CYAN in the nightly calendar.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Packaged Foods

The 12 companies below are the closest to Cyanotech Corporation by market cap within the Packaged Foods industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

StockCloseFair valueMoSWheelMkt cap
LIMX
Limitless X Holdings Inc.
0.2490--28No options$5M
GLUC
Glucose Health, Inc.
0.3600--27No options$6M
FAMI
Farmmi, Inc.
0.112863.71+100%39No options$4M
DDC
DDC Enterprise Limited
0.1727--24No options$4M
NAII
Natural Alternatives International, Inc.
1.12--27No options$7M
RGFC
The Real Good Food Company, Inc.
0.5500--24No options$9M
RELV
Reliv' International, Inc.
1.65--32No options$3M
NCRA
Nocera, Inc.
1.73--25No options$3M
HNFSB
Hanover Foods Corporation
60.101,405.28+96%31No options$13M
COOT
Australian Oilseeds Holdings Limited Ordinary Shares
0.45591.91+76%39No options$14M
TOFB
Tofutti Brands Inc.
0.3700--27No options$2M
ATPC
Agape ATP Corporation
1.67--28No options$2M

⚖ Compare CYAN with 7 of them   All Consumer Defensive stocks →

Screen the whole market the same way

A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.

Start free See the Sunday Scan

Questions about CYAN

Is CYAN undervalued right now?

No: at 0.7000 the stock trades 138% above the GLS average fair value of 0.2935 (data as of 16 Oct 2026), well beyond what trailing earnings, cash flow and book value support.

What is the Wheel Score of CYAN and what does it mean?

CYAN has no listed options in our nightly snapshot, so it cannot be wheeled; its Wheel Score is capped at 39 and shown as "No options".

What is the GLS fair value for CYAN?

0.2935 per share as of 16 Oct 2026 - the simple average of the 1 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.

When does Cyanotech Corporation report earnings next?

No upcoming earnings date is recorded for CYAN in our calendar as of 16 Oct 2026; the Calendars page is refreshed every morning.

Does CYAN have listed options, and how liquid are they?

No. The nightly options snapshot found no listed contracts on CYAN, so the wheel strategy cannot be run on it and the Wheel Score is capped at 39.

Data as of 16 Oct 2026: prices and fundamentals from Financial Modeling Prep, option data from Polygon; valuations, scores and the Wheel Score by GLS Equity's models, run nightly. Prices in USD; the close shown is the previous session's. Everything on this page is general information produced by automated models from third-party data - not a recommendation to buy, sell or trade any security or option, and not financial advice. Past performance is not indicative of future results. GLS Equity provides data and tools, not financial advice.